Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Autran

Showing results (171-180 of 201) with videos related to

Pageof 21
Sort By:
Plos One|May 22, 2013
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infectionCharline Bacchus, Antoine Cheret, Véronique Avettand-Fenoël, et al.
Frontiers in Cell and Developmental Biology|October 28, 2021
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number AlterationsAmira Bouzidi, Karim Labreche, Marine Baron, et al.
Plos One|August 9, 2016
HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected SubjectsJohannes S Gach, Andrea Gorlani, Emmanuel Y Dotsey, et al.
Frontiers in Immunology|July 26, 2024
Charting a course for global progress in PIDs by 2030 - proceedings from the IPOPI global multi-stakeholders' summit (September 2023)Samya Van Coillie, Johan Prévot, Silvia Sánchez-Ramón, et al.
The Journal of Infectious Diseases|July 20, 2005
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infectionSabine Kinloch-de Loes, Bruno Hoen, Don E Smith, et al.
Plos Pathogens|March 22, 2013
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI StudyAsier Sáez-Cirión, Charline Bacchus, Laurent Hocqueloux, et al.
Frontiers in Immunology|May 10, 2017
HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper CellsYin Xu, Chansavath Phetsouphanh, Kazuo Suzuki, et al.
Science (New York, N.Y.)|June 6, 2009
A step ahead on the HIV collaboratoryRobert L Murphy, Brigitte Autran, Christine Katlama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2021
Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal AntibodiesBenoit Bailly, Helene Péré, David Veyer, et al.
Frontiers in Immunology|September 9, 2020
Conventional Dendritic Cells and Slan<sup>+</sup> Monocytes During HIV-2 InfectionMarco Iannetta, Stéphane Isnard, Jennifer Manuzak, et al.
Pageof 21

Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
Plos One|May 22, 2013
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infectionCharline Bacchus, Antoine Cheret, Véronique Avettand-Fenoël, et al.
Frontiers in Cell and Developmental Biology|October 28, 2021
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number AlterationsAmira Bouzidi, Karim Labreche, Marine Baron, et al.
Plos One|August 9, 2016
HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected SubjectsJohannes S Gach, Andrea Gorlani, Emmanuel Y Dotsey, et al.
Frontiers in Immunology|July 26, 2024
Charting a course for global progress in PIDs by 2030 - proceedings from the IPOPI global multi-stakeholders' summit (September 2023)Samya Van Coillie, Johan Prévot, Silvia Sánchez-Ramón, et al.
The Journal of Infectious Diseases|July 20, 2005
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infectionSabine Kinloch-de Loes, Bruno Hoen, Don E Smith, et al.
Plos Pathogens|March 22, 2013
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI StudyAsier Sáez-Cirión, Charline Bacchus, Laurent Hocqueloux, et al.
Frontiers in Immunology|May 10, 2017
HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper CellsYin Xu, Chansavath Phetsouphanh, Kazuo Suzuki, et al.
Science (New York, N.Y.)|June 6, 2009
A step ahead on the HIV collaboratoryRobert L Murphy, Brigitte Autran, Christine Katlama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2021
Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal AntibodiesBenoit Bailly, Helene Péré, David Veyer, et al.
Frontiers in Immunology|September 9, 2020
Conventional Dendritic Cells and Slan<sup>+</sup> Monocytes During HIV-2 InfectionMarco Iannetta, Stéphane Isnard, Jennifer Manuzak, et al.
Pageof 21